Systemic FasL neutralization increases eosinophilic inflammation in a mouse model of asthma

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 67, Issue 3, 2012, Pages 328-335

  Sharma, S K ^a,c   Almeida, F A ^c   Kierstein, S ^a   Hortobagyi, L ^a   Lin, T ^c   Larkin, A ^c   Peterson, J ^c   Yagita, H ^b   Zangrilli, J G ^c   Haczku, A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b JUNTENDO UNIVERSITY   (Japan)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

allergen challenge; animal models; asthma; eosinophil; Fas ligand

Indexed keywords

FAS LIGAND; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 5; INTERLEUKIN 9;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPERGILLUS FUMIGATUS; ASTHMA; EOSINOPHIL COUNT; EOSINOPHILIA; LUNG LAVAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST;

ANIMALS; ASPERGILLUS FUMIGATUS; ASTHMA; BRONCHOALVEOLAR LAVAGE FLUID; CRICETINAE; DISEASE MODELS, ANIMAL; EOSINOPHILIA; EOSINOPHILS; FAS LIGAND PROTEIN; FEMALE; HUMANS; INFLAMMATION; LEUKOCYTE COUNT; LUNG; MICE; MICE, INBRED BALB C; NEUTRALIZATION TESTS;

EID: 84857195755     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2011.02763.x     Document Type: Article

References (35)

1. Suda T, Nagata S,. Purification and characterization of the Fas-ligand that induces apoptosis. J Exp Med 1994; 179: 873-879.
2. Suda T, Takahashi T, Golstein P, Nagata S,. Molecular cloning of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 1993; 75: 1169-1178.
3. Enari M, Hug H, Nagata S,. Involvement of ICE-like protease in Fas-mediated apoptosis. Nature 1995; 375: 78-81.
4. Chinnaiyan AM, O'Rourke K, Tewari M, Dixit VM,. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 1995; 81: 505-512.
5. Muzio M, Chinnaiyan AM, Kischkel FC, O'Rourke K, Shevchenko A, Ni J, et al. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 1996; 85: 817-827.
6. Luo X, Budihardjo I, Zou H, Slaughter C, Wang X,. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 1998; 94: 481-490.
7. Moorman JE, Rudd RA, Johnson CA, King M, Minor P, Bailey C, et al. National surveillance for asthma-United States, 1980-2004. MMWR Surveill Summ 2007; 56: 1-54.
8. Busse WW, Lemanske RF Jr,. Asthma. N. Engl J Med 2001; 344: 350-362.
9. Lemanske RF Jr, Sorkness CA, Mauger EA, Lazarus SC, Boushey HA, et al. Inhaled corticosteroid reduction and elimination in patients with persistent asthma receiving salmeterol: a randomized controlled trial. JAMA 2001; 285: 2594-2603.
10. Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. American Thoracic Society. [Review] [119 refs]. Am J Respir Crit Care Med 2000; 162: 2341-2351.
11. Matsumoto K, Schleimer RP, Saito H, Iikura Y, Bochner BS,. Induction of apoptosis in human eosinophils by anti-Fas antibody treatment in vitro. Blood 1995; 86: 1437-1443.
12. Brunner T, Mogil RJ, LaFace D, Yoo NJ, Mahboubi A, Echeverri F, et al. Cell-autonomous Fas(CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 1995; 373: 441-444.
13. Haczku A, Atochina EN, Tomer Y, Cao Y, Campbell C, Scanlon ST, et al. The late asthmatic response is linked with increased surface tension and reduced surfactant protein B in mice. Am J Physiol Lung Cell Mol Physiol 2002; 283: L755-L765.
14. Haczku A, Cao Y, Vass G, Kierstein S, Nath P, Atochina-Vasserman EN, et al. IL-4 and IL-13 form a negative feedback circuit with surfactant protein-D in the allergic airway response. J Immunol 2006; 176: 3557-3565.
15. Kayagaki N, Yamaguchi N, Nagao F, Matsuo S, Maeda H, Okumura K, et al. Polymorphism of murine Fas ligand that affects the biological activity. Proc Natl Acad Sci USA 1997; 94: 3914-3919.
16. Kierstein S, Krytska K, Sharma S, Amrani Y, Salmon M, Panettieri RA Jr, et al. Ozone inhalation induces exacerbation of eosinophilic airway inflammation and hyperresponsiveness in allergen-sensitized mice. Allergy 2008; 63: 438-446.
17. Haczku A, Chung KF, Sun J, Barnes PJ, Kay AB, Moqbel R,. Airway hyperresponsiveness, elevation of serum-specific IgE and activation of T cells following allergen exposure in sensitized Brown-Norway rats. Immunology 1995; 85: 598-603.
18. Hamann KJ, Dorscheid DR, Ko FD, Conforti AE, Sperling AI, Rabe KF, et al. Expression of fas (CD95) and fasL (CD95L) in human airway epithelium. Am J Respir Cell Mol Biol 1998; 19: 537-542.
19. Gochuico BR, Miranda KM, Hessel EM, De Bie JJ, Van Oosterhout AJ, Cruikshank WW, et al. Airway epithelial Fas ligand expression: potential role in modulating bronchial inflammation. Am J Physiol 1998; 274 (Pt 1): L444-L449.
20. Simon HU,. Regulation of eosinophil and neutrophil apoptosis-similarities and differences. Immunol Rev 2001; 179: 156-162.
21. Simon HU,. Cell death in allergic diseases. Apoptosis 2009; 14: 439-446.
22. Tong J, Bandulwala HS, Clay BS, Anders RA, Shilling RA, Balachandran DD, et al. Fas-positive T cells regulate the resolution of airway inflammation in a murine model of asthma. J Exp Med 2006; 203: 1173-1184.
23. Tong J, Clay BS, Ferreira CM, Bandukwala HS, Moore TV, Blaine KM, et al. Fas ligand expression on T cells is sufficient to prevent prolonged airway inflammation in a murine model of asthma. Am J Respir Cell Mol Biol 2010; 43: 342-348.
24. Tsuyuki S, Bertrand C, Erard F, Trifilieff A, Tsuyuki J, Wesp M, et al. Activation of the Fas receptor on lung eosinophils leads to apoptosis and the resolution of eosinophilic inflammation of the airways. J Clin Invest 1995; 96: 2924-2931.
25. Ohta K, Yamashita N, Tajima M, Miyasaka T, Kawashima R, Nakano J, et al. In vivo effects of apoptosis in asthma examined by a murine model. Int Arch Allergy Immunol 2001; 124: 259-261.
26. Chuang YH, Fu CL, Lo YC, Chiang BL,. Adenovirus expressing Fas ligand gene decreases airway hyper-responsiveness and eosinophilia in a murine model of asthma. Gene Ther 2004; 11: 1497-1505.
27. Uller L, Rydell-Tormanen K, Persson CG, Erjefalt JS,. Anti-Fas mAb-induced apoptosis and cytolysis of airway tissue eosinophils aggravates rather than resolves established inflammation. Respir Res 2005; 6: 90.
28. Duez C, Tomkinson A, Shultz LD, Bratton DL, Gelfand EW,. Fas deficiency delays the resolution of airway hyperresponsiveness after allergen sensitization and challenge. J Allergy Clin Immunol 2001; 108: 547-556.
29. Nagata S, Suda T,. Fas and Fas ligand: lpr and gld mutations. [Review]. Immunol Today 1995; 16: 39-43.
30. Formigli L, Papucci L, Tani A, Schiavone N, Tempestini A, Orlandini GE, et al. Aponecrosis: morphological and biochemical exploration of a syncretic process of cell death sharing apoptosis and necrosis. J Cell Physiol 2000; 182: 41-49.
31. Uller L, Andersson M, Greiff L, Persson CG, Erjefalt JS,. Occurrence of apoptosis, secondary necrosis, and cytolysis in eosinophilic nasal polyps. Am J Respir Crit Care Med 2004; 170: 742-747.
32. Bouillet P, O'Reilly LA,. CD95, BIM and T cell homeostasis. Nat Rev Immunol 2009; 9: 514-519.
33. Kayagaki N, Kawasaki A, Ebata T, Ohmoto H, Ikeda S, Inoue S, et al. Metalloproteinase-mediated release of human Fas ligand. J Exp Med 1995; 182: 1777-1783.
34. Druilhe A, Wallaert B, Tsicopoulos A, Lapa e Silva JR, Tillie-Leblond I, Tonnel AB, et al. Apoptosis, proliferation, and expression of Bcl-2, Fas, and Fas ligand in bronchial biopsies from asthmatics. Am J Respir Cell Mol Biol 1999; 19: 747-757.
35. Rivera A, Ro G, Van Epps HL, Simpson T, Leiner I, Sant'Angelo DB, et al. Innate immune activation and CD4+ T cell priming during respiratory fungal infection. Immunity 2006; 25: 665-675.